Ara
Toplam kayıt 17, listelenen: 11-17
Results of the switch from intravitreal ranibizumab to intravitreal aflibercept therapy in patients with neovascular age-related macular degeneration: A 42-month retrospective real-world study
(Medknow Publications, 09.12.2021)
Aim: The study aimed to evaluate the functional and anatomical results of patients treated with intravitreal ranibizumab (IVR) for neovascular age-related macular degeneration (n-AMD) but switched to intravitreal aflibercept ...
Consequences of seasonal allergic conjunctivitis on ocular parameters of anterior and posterior segments: An up-to-date imaging approach
(Wolters Kluwer ‑ Medknow, 2021)
Aims: To investigate consequences of seasonal allergic conjunctivitis (SAC) on the
ocular anterior and posterior segment parameters. Materials and Methods: Forty
healthy participants (mean age: 25.90 ± 5.7 years, 20 ...
Paracentral Acute Middle Maculopathy Revealing a Giant Aortic Aneurysm
(Taylor & Francis Group, 14.06.2021)
Background: This report describes a case with paracentral acute middle maculopathy revealing a giant aortic aneurysm.
Case Description: A 41-year-old man presented with unilaterally unexplained sudden vision loss in the ...
Switch to aflibercept in the treatment of neovascular age-related macular degeneration: 30-month results
(NLM (Medline), 01.05.2021)
PURPOSE: This study was conducted to evaluate visual function and changes in the central macular thickness of patients with unresponsive neovascular age-related macular degeneration who were switched from ranibizumab ...
How Traumatic is Intravitreal Ozurdex Injection?
(Taylor & Francis Inc, 2021)
Background: This study intended to illustrate a rare case of pyogenic granuloma (PG) in retinal vein occlusion (RVO) patient after dexamethasone (DEX) implant therapy. Case Description: A 58-year-old female who underwent ...
Retinal microvascular morphology versus COVID-19: What to anticipate?
(Elsevier, 18.05.2022)
Background
To investigate retinal microvascular morphological changes in previously COVID-19 infected patients using optical coherence tomography angiography (OCTA), and compare the findings to age- and gender-matched ...
Overview of Anti-VEGF Treatment Regimens and New Agents in Age-Related Macular Degeneration
(Gazi Eye Foundation, 2021)
Age-related macular degeneration (AMD), which can result in central vision loss, is among the leading causes of blindness worldwide. The beginning of the anti-vascular endothelial growth factor (anti-VEGF) era has ...